| HCG18 |
|
HLA complex group 18
|
|
|
0.722 |
0.538 |
| ZNRD1 |
Q9P1U0
|
zinc ribbon domain containing 1
|
|
0.21 |
0.653 |
0.654 |
| MICA |
Q29983
|
MHC class I polypeptide-related sequence A
|
|
5.0E-03 |
0.473 |
0.846 |
| SKIV2L |
Q15477
|
Ski2 like RNA helicase
|
|
1.3E-22 |
0.615 |
0.654 |
| GPSM3 |
Q9Y4H4
|
G protein signaling modulator 3
|
|
0.29 |
0.751 |
0.423 |
| RNF39 |
Q9H2S5
|
ring finger protein 39
|
|
2.0E-05 |
0.760 |
0.538 |
| MUC22 |
E2RYF6
|
mucin 22
|
|
1.4E-02 |
0.729 |
0.500 |
| HCG22 |
E2RYF7
|
HLA complex group 22 (gene/pseudogene)
|
|
|
0.736 |
0.423 |
| NELFE |
P18615
|
negative elongation factor complex member E
|
|
6.9E-03 |
0.686 |
0.500 |
| TRIM26 |
Q12899
|
tripartite motif containing 26
|
|
0.18 |
0.705 |
0.577 |
| CDSN |
Q15517
|
corneodesmosin
|
|
0.46 |
0.585 |
0.731 |
| GRM5 |
P41594
|
glutamate metabotropic receptor 5
|
G-protein coupled receptor
|
1.00 |
0.525 |
0.846 |
| HLA-DOB |
P13765
|
major histocompatibility complex, class II, DO beta
|
Immune response
|
1.9E-06 |
0.705 |
0.500 |
| SNHG32 |
|
small nucleolar RNA host gene 32
|
|
2.4E-02 |
0.805 |
0.308 |
| USP8P1 |
|
USP8 pseudogene 1
|
|
|
0.805 |
0.269 |
| TRIM10 |
Q9UDY6
|
tripartite motif containing 10
|
|
3.7E-09 |
0.821 |
0.269 |
| TNF |
P01375
|
tumor necrosis factor
|
Signaling
|
0.80 |
0.231 |
0.962 |
| DDR1 |
Q08345
|
discoidin domain receptor tyrosine kinase 1
|
Kinase
|
4.6E-06 |
0.497 |
0.808 |
| MUC21 |
Q5SSG8
|
mucin 21, cell surface associated
|
|
8.0E-02 |
0.743 |
0.346 |
| PSORS1C3 |
|
psoriasis susceptibility 1 candidate 3
|
|
|
0.769 |
0.269 |
| HCG27 |
|
HLA complex group 27
|
|
2.3E-02 |
0.805 |
0.346 |
| C6orf47 |
O95873
|
chromosome 6 open reading frame 47
|
|
6.6E-02 |
0.722 |
0.423 |
| LST1 |
O00453
|
leukocyte specific transcript 1
|
|
1.1E-03 |
0.792 |
0.308 |
| SNORA38 |
|
small nucleolar RNA, H/ACA box 38
|
|
|
0.890 |
0.154 |
| AIF1 |
P55008
|
allograft inflammatory factor 1
|
Calcium-binding protein
|
1.9E-06 |
0.521 |
0.808 |